Abstract
Despite recent advances in microsurgical techniques, functional recovery following peripheral nerve injury remains slow and inadequate. Poor peripheral nerve regeneration not only leaves patients with significant impairments, but also commonly leads to the development of debilitating neuropathic pain. Recent research has demonstrated the potential therapeutic benefits of adipose-derived stem cells, to enhance nerve regeneration. However, clinical translation remains limited due to the current regulatory burdens of the US FDA. A reliable and immediately translatable alternative is autologous fat grafting, where native adipose-derived stem cells present in the transferred tissue can potentially act upon regenerating axons. This review presents the scope of adipose tissue-based therapies to enhance outcomes following peripheral nerve injury, specifically focusing on their role in regeneration and ameliorating neuropathic pain.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1. . Trends and cost-analysis of lower extremity nerve injury using the National Inpatient Sample. Neurosurgery 85(2), 250–256 (2019).
- 2. . The incidence of peripheral nerve injury in extremity trauma. Am. J. Phys. Med. Rehabil. 87(5), 381–385 (2008).
- 3. . Techniques of peripheral nerve repair. Scand. J. Surg. 97(4), 310–316 (2008).
- 4. Alleviated tension at the repair site enhances functional regeneration: the effect of full range of motion mobilization on the regeneration of peripheral nerves—histologic, electrophysiologic and functional results in a rat model. J. Trauma Acute Care Surg. 56(3), 571–584 (2004).
- 5. . Impaired nerve regeneration and Schwann cell activation after repair with tension. Neuroreport 21(14), 958–962 (2010).
- 6. . The role of timing in nerve reconstruction. Int. Rev. Neurobiol. 109, 151–164 (2013).
- 7. . Peripheral nerve reconstruction after injury: a review of clinical and experimental therapies. BioMed Res. Int. 2014, 13 (2014).
- 8. . Biologic strategies to improve nerve regeneration after peripheral nerve repair. J. Reconstr. Microsurg. 31(04), 243–248 (2015).
- 9. . State-of-the-art techniques in treating peripheral nerve injury. Plast. Reconstr. Surg. 141(3), 702–710 (2018).
- 10. . Emerging role of Schwann cells in neuropathic pain: receptors, glial mediators and myelination. Front. Cell. Neurosci. 13, 116 (2019).
- 11. . Wallerian degeneration and peripheral nerve conditions for both axonal regeneration and neuropathic pain induction. Ann. Anat. 193(4), 267–275 (2011).
- 12. . Mechanisms for reducing neuropathic pain. Mol. Neurobiol. 57(1), 67–87 (2020).
- 13. . Schwann cells, neurotrophic factors and peripheral nerve regeneration. Microsurgery 18(7), 397–405 (1998).
- 14. . Nerve regeneration: understanding biology and its influence on return of function after nerve transfers. Hand Clin. 32(2), 103–117 (2016).
- 15. . Role of chronic Schwann cell denervation in poor functional recovery after nerve injuries and experimental strategies to combat it. Neurosurgery 65(Suppl. 4), A105–A114 (2009).
- 16. . Schwann cell‐derived exosomes enhance axonal regeneration in the peripheral nervous system. Glia 61(11), 1795–1806 (2013).
- 17. . Peripheral nerve injuries treatment: a systematic review. Cell Biochem. Biophys. 68(3), 449–454 (2014).
- 18. . Stem‐cell–based therapies to enhance peripheral nerve regeneration. Muscle Nerve 61(4), 449–459 (2020).
- 19. . The potential roles for adipose tissue in peripheral nerve regeneration. Microsurgery 36(1), 81–88 (2016).
- 20. New approach for the treatment of neuropathic pain: fibroblast growth factor 1 gene‐transfected adipose‐derived mesenchymal stem cells. Eur. J. Pain 22(2), 295–310 (2018).
- 21. . Adipose-derived stem cells and nerve regeneration: promises and pitfalls. Int. Rev. Neurobiol. 108, 121–136 (2013).
- 22. . Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation. Stem Cell. Res. Ther. 8(1), 145 (2017).
- 23. . Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone‐marrow stromal cells. Eur. J. Neurosci. 14(11), 1771–1776 (2001).
- 24. Neurospheres from rat adipose-derived stem cells could be induced into functional Schwann cell-like cells in vitro. BMC Neurosci. 9(1), 21 (2008).
- 25. . Peripheral glial cell differentiation from neurospheres derived from adipose mesenchymal stem cells. Int. J. Dev. Neurosci. 27(8), 817–823 (2009).
- 26. Schwann‐like cell differentiation of rat adipose‐derived stem cells by indirect co‐culture with Schwann cells in vitro. Cell Prolif. 43(6), 606–616 (2010).
- 27. . Neurotrophic activity of human adipose stem cells isolated from deep and superficial layers of abdominal fat. Cell Tissue Res. 344(2), 251–260 (2011).
- 28. . Glial differentiation of human adipose-derived stem cells: implications for cell-based transplantation therapy. Neuroscience 236, 55–65 (2013).
- 29. . Combined use of decellularized allogeneic artery conduits with autologous transdifferentiated adipose-derived stem cells for facial nerve regeneration in rats. Biomaterials 32(32), 8118–8128 (2011).
- 30. . Differentiated adipose‐derived stem cells promote myelination and enhance functional recovery in a rat model of chronic denervation. J. Neurosci. Res. 90(7), 1392–1402 (2012).
- 31. . Adipose-derived stem cells enhance peripheral nerve regeneration. J. Plast. Reconstr. Aesthet. Surg. 63(9), 1544–1552 (2010).
- 32. . Mesenchymal stem cells isolated from adipose and other tissues: basic biological properties and clinical applications. Stem Cells Int. 2012, 461718 (2012).
- 33. . Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr. Stem Cell Res. Ther. 5(2), 103–110 (2010).
- 34. . Review of the adipose derived stem cell secretome. Biochimie 95(12), 2222–2228 (2013).
- 35. Adipose-derived stem cells promote peripheral nerve regeneration in vivo without differentiation into Schwann-like lineage. Plast. Reconstr. Surg. 137(2), 318e–330e (2016).
- 36. . Long-term in vivo regeneration of peripheral nerves through bioengineered nerve grafts. Neuroscience 181, 278–291 (2011).
- 37. . Effect of an epineurial-like biohybrid nerve conduit on nerve regeneration. Cell Transplant. 25(3), 559–574 (2016).
- 38. . Poly‐3‐hydroxybutyrate strips seeded with regenerative cells are effective promoters of peripheral nerve repair. J. Tissue Eng. Regen. Med. 11(3), 812–821 (2017).
- 39. Recellularized nerve allografts with differentiated mesenchymal stem cells promote peripheral nerve regeneration. Neurosci. Lett. 514(1), 96–101 (2012).
- 40. . Adipose-derived neural stem cells combined with acellular dermal matrix as a neural conduit enhances peripheral nerve repair. Cell Transplant. 28(9-10), 1220–1230 (2019).
- 41. Allogenic adipose derived stem cells transplantation improved sciatic nerve regeneration in rats: autologous nerve graft model. Front. Pharmacol. 9, 86 (2018).
- 42. Combination of fibrin-agarose hydrogels and adipose-derived mesenchymal stem cells for peripheral nerve regeneration. J. Neural Eng. 10(2), 026022 (2013).
- 43. Therapeutic effects of nerve leachate-treated adipose-derived mesenchymal stem cells on rat sciatic nerve injury. Exp. Ther. Med. 19(1), 223–231 (2020).
- 44. In vivo effects of adipose-derived stem cells in inducing neuronal regeneration in Sprague-Dawley rats undergoing nerve defect bridged with polycaprolactone nanotubes. J. Korean Med. Sci. 29(Suppl. 3), S183–S192 (2014).
- 45. . Undifferentiated and differentiated adipose‐derived stem cells improve nerve regeneration in a rat model of facial nerve defect. J. Tissue Eng. Regen. Med. 11(2), 362–374 (2017).
- 46. . The role of undifferentiated adipose-derived stem cells in peripheral nerve repair. Neural Regen. Res. 13(5), 757 (2018).
- 47. Adipose‐derived stem cells and the stromal vascular fraction in polyglycolic acid‐collagen nerve conduits promote rat facial nerve regeneration. Wound Repair Regen. 26(6), 446–455 (2018).
- 48. . Facial‐nerve regeneration ability of a hybrid artificial nerve conduit containing uncultured adipose‐derived stromal vascular fraction: an experimental study. Microsurgery 37(7), 808–818 (2017). • While SVF contains a lower concentration of ADSCs, it was still able to improve nerve regeneration similar to the purified and cultured ADSCs in rats.
- 49. Uncultured adipose-derived regenerative cells promote peripheral nerve regeneration. J. Orthop. Sci. 18(1), 145–151 (2013).
- 50. . Transplantation of uncultured omental adipose-derived stromal vascular fraction improves sciatic nerve regeneration and functional recovery through inside-out vein graft in rats. J. Trauma Acute Care Surg. 72(2), 390–396 (2012).
- 51. . Repair of nerve defect with chitosan graft supplemented by uncultured characterized stromal vascular fraction in streptozotocin induced diabetic rats. Int. J. Surg. 12(1), 33–40 (2014).
- 52. . Uncultured undifferentiated adipose-derived nucleated cell fractions combined with inside-out artery graft accelerate sciatic nerve regeneration and functional recovery. Int. J. Oral Maxillofac. Surg. 43(9), 1161–1168 (2014).
- 53. Effect of white adipose tissue flap and insulin‐like growth factor‐1 on nerve regeneration in rats. Microsurgery 33(5), 367–375 (2013).
- 54. The effect of autologous fat graft with different surgical repair methods on nerve regeneration in a rat sciatic nerve defect model. Plast. Reconstr. Surg. 136(6), 1181–1191 (2015). • Fat grafting enhanced nerve regeneration with subsequent improvement in motor and sensory functions in a rat model of nerve injury.
- 55. Adipose tissue graft improves early but not late stages of nerve regeneration. In Vivo 31(4), 649–655 (2017).
- 56. Functional recoveries of sciatic nerve regeneration by combining chitosan-coated conduit and neurosphere cells induced from adipose-derived stem cells. Biomaterials 35(7), 2234–2244 (2014).
- 57. Adipose-derived stem cells promote peripheral nerve repair. Arch. Med. Sci. 7(4), 592 (2011).
- 58. Validation of a novel animal model for sciatic nerve repair with an adipose-derived stem cell loaded fibrin conduit. Neural Regen. Res. 13(5), 854 (2018).
- 59. . The current state of fat grafting: a review of harvesting, processing and injection techniques. Plast. Reconstr. Surg. 136(4), 897 (2015).
- 60. . Injury-induced effectors of neuropathic pain. Mol. Neurobiol. 57(1), 51–66 (2020).
- 61. . Exosomes from adipose-derived stem cells alleviate neural injury caused by microglia activation via suppressing NF-kB and MAPK pathway. J. Neuroimmunol. 334, 576996 (2019).
- 62. . Active nerve regeneration with failed target reinnervation drives persistent neuropathic pain. eNeuro 4(1), 1–16 (2017). •• The incomplete process of nerve regeneration can be directly associated with neuropathic pain development.
- 63. Natural killer cells degenerate intact sensory afferents following nerve injury. Cell 176(4), 716–728.e718 (2019).
- 64. . Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J. Pain 10(9), 895–926 (2009).
- 65. . Neuropathic pain: central vs. peripheral mechanisms. Curr. Pain Headache Rep. 21(6), 28 (2017).
- 66. . BDNF contributes to animal model neuropathic pain after peripheral nerve transection. Neurosurg. Rev. 30(3), 235–243 (2007).
- 67. . Regeneration patterns influence hindlimb automutilation after sciatic nerve repair using stem cells in rats. Neurosci. Lett. 634, 153–159 (2016).
- 68. Human adipose stem cells improve mechanical allodynia and enhance functional recovery in a rat model of neuropathic pain. Tissue Eng. Part A 21(13-14), 2044–2052 (2015).
- 69. . Long-term actions of interleukin-1β on K+, Na+ and Ca2+ channel currents in small, IB4-positive dorsal root ganglion neurons; possible relevance to the etiology of neuropathic pain. J. Neuroimmunol. 332, 198–211 (2019).
- 70. . Increased excitability of medium‐sized dorsal root ganglion neurons by prolonged interleukin‐1β exposure is K+ channel dependent and reversible. J. Physiol. 593(16), 3739–3755 (2015).
- 71. . TNF-α differentially modulates ion channels of nociceptive neurons. Neurosci. Lett. 434(3), 293–298 (2008).
- 72. . Afferent hyperexcitability in neuropathic pain and the inconvenient truth about its degeneracy. Curr. Opin. Neurobiol. 36, 31–37 (2016).
- 73. . The expression of α-SMA in the painful traumatic neuroma: potential role in the pathobiology of neuropathic pain. J. Neurotrauma 29(18), 2791–2797 (2012).
- 74. Nerve capping with a nerve conduit for the treatment of painful neuroma in the rat sciatic nerve. J. Neurosurg.
doi:10.3171/2018.10.JNS182113 (2019) (Epub ahead of print). - 75. Autologous fat grafting alleviates burn-induced neuropathic pain in rats. Plast. Reconstr. Surg. 133(6), 1396–1405 (2014).
- 76. . Peripheral neuropathy and nerve compression syndromes in burns. Clin. Plast. Surg. 44(4), 793–803 (2017).
- 77. . Astrocytes in chronic pain and itch. Nat. Revi. Neurosci. 20(11), 667–685 (2019).
- 78. Dorsal root ganglion macrophages contribute to both the initiation and persistence of neuropathic pain. Nat. Commun. 11(1), 1–12 (2020).
- 79. . Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential. Nat. Rev. Neurosci. 19(3), 138 (2018).
- 80. . Do glial cells control pain? Neuron Glia Biol. 3(3), 255–268 (2007).
- 81. . Interleukin-18-mediated microglia/astrocyte interaction in the spinal cord enhances neuropathic pain processing after nerve injury. J. Neurosci. 28(48), 12775–12787 (2008).
- 82. . NF-kappaB signaling pathways in neurological inflammation: a mini review. Front. Mol. Neurosci. 8, 77 (2015).
- 83. Therapeutic effect of human adipose-derived stem cells and their secretome in experimental diabetic pain. Sci. Rep. 7(1), 1–15 (2017). • ADSCs and their secretomes mitigated central and peripheral neuronal inflammation and subsequently improved neuropathic pain in diabetic rats.
- 84. . Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 20(5-6), 419–427 (2009).
- 85. . Exosome mediated delivery of miR-124 promotes neurogenesis after ischemia. Mol. Ther. Nucleic Acids 7, 278–287 (2017).
- 86. Multipotent mesenchymal stromal cell–derived exosomes improve functional recovery after experimental intracerebral hemorrhage in the rat. J. Neurosurg. 131(1), 290–300 (2018).
- 87. . Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy. Stem Cells Int. 2012, 342968 (2012).
- 88. . Neural differentiation and therapeutic potential of adipose tissue derived stem cells. Curr. Stem Cell Res. Ther. 5(2), 153–160 (2010).
- 89. Systemic administration of human adipose-derived stem cells reverts nociceptive hypersensitivity in an experimental model of neuropathy. Stem Cells Dev. 22(8), 1252–1263 (2013).
- 90. . Pulsed magnetic field enhances therapeutic efficiency of mesenchymal stem cells in chronic neuropathic pain model. Bioelectromagnetics 38(4), 255–264 (2017).
- 91. Fat grafting in burn scar alleviates neuropathic pain via anti-inflammation effect in scar and spinal cord. PLoS ONE 10(9), 1–13 (2015).
- 92. Autologous adipose-derived stem cells reduce burn-induced neuropathic pain in a rat model. Int. J. Mol. Sci. 19(1), 34 (2018).
- 93. Safety and potential effect of a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical prostatectomy: an open-label Phase I clinical trial. EBioMedicine 5, 204–210 (2016). •• SVF injection into the corpus cavernosum improved erectile dysfunction in patients whose neurovascular bundle had been severed due to the radical prostatectomy surgery.
- 94. Prevention and management of postprostatectomy sexual dysfunctions part 1: choosing the right patient at the right time for the right surgery. Eur. Urol. 62(2), 261–272 (2012).
- 95. A 12-month follow-up after a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical prostatectomy: an open-label Phase I clinical trial. Urology 121, 203.e206–203.e213 (2018).
- 96. . Neuropathic pain in the general population: a systematic review of epidemiological studies. PAIN® 155(4), 654–662 (2014).
- 97. . The role of fat grafting in alleviating neuropathic pain: a critical review of the literature. Plast. Reconstr. Surg.Global Open 7(5), 1–8 (2019).
- 98. . Prevalence, characteristics and impact of postmastectomy pain syndrome: an investigation of women's experiences. Pain 61(1), 61–68 (1995).
- 99. . Autologous fat graft in postmastectomy pain syndrome. Plast. Reconstr. Surg. 128(2), 349–352 (2011).
- 100. Autologous fat graft in postmastectomy pain syndrome following breast conservative surgery and radiotherapy. Aesthetic Plast. Surg. 38(3), 528–532 (2014).
- 101. . Autologous fat grafting reduces pain in irradiated breast: a review of our experience. Stem Cells Int. 2016, 1–5 (2016).
- 102. . Fat grafting for alleviating persistent pain after breast cancer treatment: a randomized controlled trial. J. Plast. Reconstr. Aesthet. Surg. 69(9), 1192–1202 (2016). • Autologous fat grafting reduced post-mastectomy neuropathic pain and enhanced the quality of life.
- 103. . The role of lipofilling after breast reconstruction: evaluation of outcomes and patient satisfaction with BREAST-Q. Aesthetic Plast. Surg. 41(6), 1325–1331 (2017).
- 104. . Perineural fat grafting in the treatment of painful end-neuromas of the upper limb: a pilot study. J. Hand Surg. 38(1), 36–42 (2013).
- 105. . Perineural fat grafting in end-neuroma pain treatment: long-term outcomes. Eur. J. Plast. Surg. 37, 1–6 (2020).
- 106. . The novel treatment of SVF‐enriched fat grafting for painful end‐neuromas of superficial radial nerve. Microsurgery 38(3), 264–269 (2016).
- 107. . Outcome of stromal vascular fraction-enriched fat grafting compared to intramuscular transposition in painful end-neuromas of superficial radial nerve: preliminary results. Frontiers Surg. 5, 10 (2018).
- 108. Amputation-site soft-tissue restoration using adipose stem cell therapy. Plast. Reconstr. Surg. 142(5), 1349–1352 (2018).
- 109. . Fat grafting for neuropathic pain after severe burns. Ann. Plast. Surg. 76, S298–S303 (2016). • Autologous fat grafting significantly reduced pain in burn patients with refractory neuropathic pain to the previous medical and surgical interventions.
- 110. . Unilateral upper-limb loss: satisfaction and prosthetic-device use in veterans and servicemembers from Vietnam and OIF/OEF conflicts. J. Rehabil. Res. Dev. 47(4), 299–316 (2010).
- 111. . Use of lipomodeling to forearm residuum to assist fitting of below-elbow prosthesis. J. Prosthetics Orthotics 24(1), 50–51 (2012).
- 112. Changes in cutaneous innervation in patients with chronic pain after burns. Burns 37(4), 631–637 (2011).
- 113. . Enhanced inflammatory hyperalgesia after recovery from burn injury. Burns 33(8), 1021–1026 (2007).
- 114. Autologous fat graft in scar treatment. J. Craniofac. Surg. 24(5), 1610–1615 (2013).
- 115. . Intra-and inter-examiner variability in performing Tinel's test. J. Hand Surg. 35(2), 212–216 (2010).
- 116. . The FDA and the US direct-to-consumer marketplace for stem cell interventions: a temporal analysis. Regen. Med. 13(1), 19–27 (2018).
- 117. . Lipotransfer: the potential from bench to bedside. Ann. Plast. Surg. 72(5), 599–609 (2014).
- 118. Concise review: fat and furious: Harnessing the full potential of adipose‐derived stromal vascular fraction. Stem Cells Transl. Med. 6(4), 1096–1108 (2017). • At the current state, only autologous fat grafting is considered safe and applicable to the clinical practice.
- 119. NurOwn, phase 2, randomized, clinical trial in patients with ALS: safety, clinical and biomarker results. Neurology 93(24), e2294–e2305 (2019).
- 120. Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis. Mult. Scler. 24(4), 501–511 (2018).
- 121. Emerging safety of intramedullary transplantation of human neural stem cells in chronic cervical and thoracic spinal cord injury. Neurosurgery 82(4), 562–575 (2018).
- 122. . Phase I/II study of safety and preliminary efficacy of intravenous allogeneic mesenchymal stem cells in chronic stroke. Stroke 50(10), 2835–2841 (2019).
- 123. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13(12), 4279–4295 (2002).
- 124. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. Plast. Reconstr. Surg. 119(5), 1409–1422 (2007).
- 125. Multipotential differentiation of adipose tissue-derived stem cells. Keio J. Med. 54(3), 132–141 (2005).